All news

Moderna executives sell $30 million under June trading plans

Alpha Vantage · WSJ · · AI-summarised by FinFlash

Moderna CFO James Mock and President Stephen Hoge sold more than $30 million in shares after a cancer vaccine study lifted the stock, and before fuller results tempered gains. The sales ran under pre-set trading plans adopted in June, before the August announcement of positive vaccine data.

Read original source

MRNA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.